01131nas a2200301 4500000000100000008004100001260001700042653002700059653001500086653001000101653000900111653001100120653001100131653001300142653001200155653001500167653000900182653001600191100001400207700001200221700001200233245007300245300000900318490000700327050003200334520044900366022001400815 1985 d c1985 Jan-Mar10aAdjuvants, Immunologic10aAdolescent10aAdult10aAged10aFemale10aHumans10aLepromin10aleprosy10aLevamisole10aMale10aMiddle Aged1 aArora S K1 aSingh G1 aSen P C00aImmuno-stimulatory effect of levamisole in borderline leprosy cases. a22-60 v57 aInfolep Library - available3 a
Eleven cases of borderline-borderline leprosy were subjected to levamisole therapy for 3 months. Levamisole was given 150 mg/day on three consecutive days every fortnight along with dapsone (DDS). Immuno-stimulation was assessed by lepromin test using Lepromin-A supplied by W.H.O. containing 4.0 X 10(7) bacilli per milli litre. It was found that there was statistically significant change in lepromin reaction after levamisole therapy.
a0254-9395